Analystreport

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus.

MOMENTA PHARMACEUTICALS  (MNTA) 
Last momenta pharmaceuticals earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.momentapharma.com/investor-relations